Advertisement
Loading...

BillionToOne, Inc.

BLLNNASDAQ
Healthcare
Medical - Diagnostics & Research
$82.63
$-5.31(-6.04%)
U.S. Market opens in 37h 17m

BillionToOne, Inc. Fundamental Analysis

BillionToOne, Inc. (BLLN) shows weak financial fundamentals with a PE ratio of 151.26, profit margin of 7.11%, and ROE of 7.55%. The company generates $0.4B in annual revenue with strong year-over-year growth of 99.97%.

Key Strengths

Cash Position14.16%
PEG Ratio0.03
Current Ratio10.92

Areas of Concern

ROE7.55%
We analyze BLLN's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of 61.0/100 based on profitability, valuation, growth, and balance sheet metrics. The C+ grade reflects average fundamentals, with notable risks in certain areas.

Fundamental Health Score

C+
61.0/100

We analyze BLLN's fundamental strength across five key dimensions:

Efficiency Score

Weak

BLLN struggles to generate sufficient returns from assets.

ROA > 10%
3.60%

Valuation Score

Moderate

BLLN shows balanced valuation metrics.

PE < 25
151.26
PEG Ratio < 2
0.03

Growth Score

Moderate

BLLN shows steady but slowing expansion.

Revenue Growth > 5%
99.97%
EPS Growth > 10%
1.07%

Financial Health Score

Excellent

BLLN maintains a strong and stable balance sheet.

Debt/Equity < 1
0.29
Current Ratio > 1
10.92

Profitability Score

Weak

BLLN struggles to sustain strong margins.

ROE > 15%
7.55%
Net Margin ≥ 15%
7.11%
Positive Free Cash Flow
Yes

Key Financial Metrics

Is BLLN Expensive or Cheap?

P/E Ratio

BLLN trades at 151.26 times earnings. This suggests a premium valuation.

151.26

PEG Ratio

When adjusting for growth, BLLN's PEG of 0.03 indicates potential undervaluation.

0.03

Price to Book

The market values BillionToOne, Inc. at 7.54 times its book value. This suggests the stock is fully valued or overvalued on an asset basis.

7.54

EV/EBITDA

Enterprise value stands at 102.08 times EBITDA. This signals the market has high growth expectations.

102.08

How Well Does BLLN Make Money?

Net Profit Margin

For every $100 in sales, BillionToOne, Inc. keeps $7.11 as profit after all expenses.

7.11%

Operating Margin

Core operations generate 10.20 in profit for every $100 in revenue, before interest and taxes.

10.20%

ROE

Management delivers $7.55 in profit for every $100 of shareholder equity.

7.55%

ROA

BillionToOne, Inc. generates $3.60 in profit for every $100 in assets, demonstrating efficient asset deployment.

3.60%

Following the Money - Real Cash Generation

Operating Cash Flow

BillionToOne, Inc. produces operating cash flow of $36.27M, showing steady but balanced cash generation.

$36.27M

Free Cash Flow

BillionToOne, Inc. produces free cash flow of $28.13M, offering steady but limited capital for shareholder returns and expansion.

$28.13M

FCF Per Share

Each share generates $0.61 in free cash annually.

$0.61

FCF Yield

BLLN converts 0.73% of its market value into free cash.

0.73%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

151.26

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

0.03

vs 25 benchmark

P/B Ratio

Price to book value ratio

7.54

vs 25 benchmark

P/S Ratio

Price to sales ratio

10.77

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

0.29

vs 25 benchmark

Current Ratio

Current assets to current liabilities

10.92

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

0.08

vs 25 benchmark

ROA

Return on assets percentage

0.04

vs 25 benchmark

ROCE

Return on capital employed

0.06

vs 25 benchmark

How BLLN Stacks Against Its Sector Peers

MetricBLLN ValueSector AveragePerformance
P/E Ratio151.2628.62 Worse (Expensive)
ROE7.55%783.00% Weak
Net Margin7.11%-48181.00% (disorted) Weak
Debt/Equity0.290.39 Strong (Low Leverage)
Current Ratio10.924.12 Strong Liquidity
ROA3.60%-21914.00% (disorted) Weak

BLLN outperforms its industry in 2 out of 6 key metrics, but lagging in P/E Ratio.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews BillionToOne, Inc.'s 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

315.30%

Industry Style: Defensive, Growth, Innovation

High Growth

EPS CAGR

108.80%

Industry Style: Defensive, Growth, Innovation

High Growth

FCF CAGR

144.74%

Industry Style: Defensive, Growth, Innovation

High Growth

Fundamental Analysis FAQ